Galsulfase
DrugBank ID: DB01279
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 1 |
| DL Only | 49 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| ptosis-strabismus-ectopic pupils syndrome | 0.9789 | DL |
| camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye | 0.9787 | DL |
| congenital Horner syndrome (disease) | 0.9784 | DL |
| ptosis-vocal cord paralysis syndrome | 0.9783 | DL |
| ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome | 0.9767 | DL |
| jaw-winking syndrome | 0.9765 | DL |
| congenital entropion | 0.9764 | DL |
| epiblepharon | 0.9755 | DL |
| congenital ectropion | 0.9748 | DL |
| mucopolysaccharidosis | 0.9693 | KG+DL |
| Scheie syndrome | 0.9479 | DL |
| Steel syndrome | 0.9388 | DL |
| inborn disorder of lysosomal amino acid transport | 0.9243 | DL |
| proximal myopathy with extrapyramidal signs | 0.9131 | DL |
| Hurler syndrome | 0.9023 | DL |
| Charcot-Marie-Tooth disease | 0.9005 | DL |
| Sanfilippo syndrome | 0.8867 | DL |
| lysosomal storage disease with skeletal involvement | 0.8799 | DL |
| alpha-mannosidosis | 0.8723 | DL |
| skeletal muscle disease | 0.8619 | DL |
| hypophosphatasia | 0.8590 | DL |
| inclusion myopathy | 0.8421 | DL |
| phosphoribosylpyrophosphate synthetase superactivity | 0.7904 | DL |
| ocular cystinosis | 0.7873 | DL |
| esophageal varices with bleeding | 0.7789 | DL |
| esophageal varices without bleeding | 0.7789 | DL |
| myoclonic epilepsy, juvenile, susceptibility to | 0.7614 | DL |
| familial encephalopathy with neuroserpin inclusion bodies | 0.7539 | DL |
| infantile neuronal ceroid lipofuscinosis | 0.7378 | DL |
| lysosomal disease with hypertrophic cardiomyopathy | 0.7327 | DL |
| syndromic neurometabolic disease with X-linked intellectual disability | 0.7305 | DL |
| growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant | 0.7301 | DL |
| eyelids malposition disorder | 0.7293 | DL |
| Tay-Sachs disease | 0.7140 | DL |
| adolescent/adult-onset epilepsy syndrome | 0.7136 | DL |
| adolescence-adult electroclinical syndrome | 0.6972 | DL |
| adult Krabbe disease | 0.6913 | DL |
| mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies | 0.6801 | DL |
| reticular dysgenesis | 0.6691 | DL |
| Oguchi disease | 0.6655 | DL |
| optic atrophy 10 with or without ataxia, intellectual disability, and seizures | 0.6654 | DL |
| TBCK-related intellectual disability syndrome | 0.6622 | DL |
| osteosclerotic metaphyseal dysplasia | 0.6621 | DL |
| mucolipidosis type III gamma | 0.6596 | DL |
| hereditary xanthinuria | 0.6592 | DL |
| lathosterolosis | 0.6558 | DL |
| trichohepatoenteric syndrome | 0.6516 | DL |
| familial generalized lentiginosis | 0.6502 | DL |
| hereditary myopathy with lactic acidosis due to ISCU deficiency | 0.6496 | DL |
| arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome | 0.6444 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.